Ask AI
Bill114th CongressFiled Mar 26, 2015Health
H.R. 1725

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house amended (Sep 8, 2015)

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

(Sec. 2) Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.

(Sec. 3) Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:

  • allow grants to be used to maintain and operate existing state controlled substance monitoring programs,
  • require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees,
  • require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and
  • expand the program to include any commonwealth or territory of the United States.

Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

What just happenedSep 9, 2015

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Rep. Whitfield, Ed [R-KY-1](R-KY)Sponsor
13 cosponsors8 D5 R
Read on Congress.gov
13cosponsors2committees18actions4related bills11subjects
  1. Sep 9, 2015IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. Sep 8, 2015FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Sep 8, 2015FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5796-5797)

  4. Sep 8, 2015Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5796-5797)

  5. Sep 8, 2015FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 1725.

  6. Sep 8, 2015FloorH30000

    Considered under suspension of the rules. (consideration: CR H5796-5798)

  7. Sep 8, 2015FloorH30300

    Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

  8. Sep 8, 2015CalendarsH12410

    Placed on the Union Calendar, Calendar No. 186.

  9. Sep 8, 2015CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 114-245.

    Energy and Commerce Committee
  10. Sep 8, 2015Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 114-245.

    Energy and Commerce Committee
  11. Jul 29, 2015Committee

    Ordered to be Reported by Voice Vote.

    Energy and Commerce Committee
  12. Jul 29, 2015Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  13. Jul 23, 2015Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Health Subcommittee
  14. Jul 23, 2015Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  15. Mar 27, 2015Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  16. Mar 26, 2015IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  17. Mar 26, 2015IntroReferralIntro-H

    Introduced in House

  18. Mar 26, 2015IntroReferral1000

    Introduced in House

Passed House amendedSep 8, 201536

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

(Sec. 2) Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.

(Sec. 3) Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:

  • allow grants to be used to maintain and operate existing state controlled substance monitoring programs,
  • require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees,
  • require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and
  • expand the program to include any commonwealth or territory of the United States.

Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

Introduced in HouseMar 26, 2015

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.

Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:

  • allow grants to be used to maintain and operate existing state controlled substance monitoring programs,
  • require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees,
  • require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and
  • expand the program to include any commonwealth or territory of the United States.

Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 — Informed